These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24673339)

  • 41. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
    Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH
    Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors.
    Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Rossing K; Hansen TW; Rossing P
    Diabetes Care; 2014 Jun; 37(6):1660-7. PubMed ID: 24623028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of bariatric surgery on estimated glomerular filtration rate in patients with type 2 diabetes: a retrospective cohort study.
    Mirajkar N; Bellary S; Ahmed M; Singhal R; Daskalakis M; Tahrani AA
    Surg Obes Relat Dis; 2016 Dec; 12(10):1883-1889. PubMed ID: 27516220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
    Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
    Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The glucagon-like peptide-1 receptor agonist, liraglutide, attenuates the progression of overt diabetic nephropathy in type 2 diabetic patients.
    Imamura S; Hirai K; Hirai A
    Tohoku J Exp Med; 2013 Sep; 231(1):57-61. PubMed ID: 24064677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes.
    Porrini E; Ruggenenti P; Mogensen CE; Barlovic DP; Praga M; Cruzado JM; Hojs R; Abbate M; de Vries AP;
    Lancet Diabetes Endocrinol; 2015 May; 3(5):382-91. PubMed ID: 25943757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus.
    Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
    Ren Fail; 2018 Nov; 40(1):590-596. PubMed ID: 30371119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy.
    Zhuo L; Zhang N; Zou G; Chen D; Li W
    Front Med; 2017 Sep; 11(3):386-392. PubMed ID: 28871455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting the progression of diabetic nephropathy and its complications: a single-center experience in Saudi Arabia.
    Alwakeel JS; Isnani AC; Alsuwaida A; Alharbi A; Shaffi SA; Almohaya S; Al Ghonaim M
    Ann Saudi Med; 2011; 31(3):236-42. PubMed ID: 21623051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum uric acid levels and decreased estimated glomerular filtration rate in patients with type 2 diabetes: A cohort study and meta-analysis.
    Wang J; Yu Y; Li X; Li D; Xu C; Yuan J; Wei S; Li X; Yang K; Zheng D; Tang Y; Yang H; Wu T; He M
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3046. PubMed ID: 30003679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes.
    Ortega Moreno L; Lamacchia O; Copetti M; Salvemini L; De Bonis C; De Cosmo S; Cignarelli M; Trischitta V; Menzaghi C
    PLoS One; 2015; 10(10):e0140631. PubMed ID: 26465607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis and management of diabetic nephropathy].
    Kitada M; Koya D
    Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obstructive sleep apnea and diabetic nephropathy: a cohort study.
    Tahrani AA; Ali A; Raymond NT; Begum S; Dubb K; Altaf QA; Piya MK; Barnett AH; Stevens MJ
    Diabetes Care; 2013 Nov; 36(11):3718-25. PubMed ID: 24062320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetes.
    Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
    Biomed Res Int; 2013; 2013():309294. PubMed ID: 24471138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
    Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
    Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial).
    Ruggenenti P; Cortinovis M; Trillini M; Parvanova A; Abbate M; Satriano C; Salvetti F; Bossi AC; Trevisan R; Perna A; Peracchi T; Rubis N; Diadei O; Martinetti D; Gaspari F; Fontana L; Remuzzi G; ;
    Diabetes Res Clin Pract; 2022 Mar; 185():109804. PubMed ID: 35219762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.